M. Okuno

Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)

Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba et al. · Journal for ImmunoTherapy of Cancer · 2020 · 63 citations · Full text

Medicine, Oncology, Pharmacology +15

Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study

Isamu Okamoto, Kazuko Sakai, Satoshi Morita et al. · Oncotarget · 2014 · 32 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study

Kentaro Ito, Takeharu Yamanaka, Hidetoshi Hayashi et al. · European Journal of Cancer · 2021 · 30 citations

Pharmacy, Oncology, Pharmacotherapy +15

Esophagomediastinal Fistula as a Complication of Tuberculous Mediastinal Lymphadenitis.

Masatoshi Ohtake, Hiroshi Saito, M. Okuno et al. · Internal Medicine · 1996 · 18 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

Positive outcome of first-line therapy for a SMARCA4-deficient thoracic sarcomatoid tumor

Shigeru Tanaka, Shuhei Hayashi, Yoshitaka Isobe et al. · International Cancer Conference Journal · 2021 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +6